The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to October 31, 2025. The next update of data is scheduled for early March, 2026.
The list of new safety and effectiveness reviews has been updated and now includes safety reviews initiated between December 1 and 31, 2025. The next update is scheduled for March 2026.
Content: Safety brief: Potential risks of radiofrequency microneedling; Safety brief: The use of some natural health products and the potential risk of hepatotoxicity; Notice of authorization with conditions: Wegovy (semaglutide)
The data presented in the Canada Vigilance Adverse Reaction Online Database has been updated and now includes information received by Health Canada up to September 30, 2025. The next update of data is scheduled for early February, 2026.
